search
Back to results

Compare the Healing Process of Idiopathic Macular Hole With Different Surgical Techniques

Primary Purpose

Macular Holes

Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Conventional ILM Peeling
Inverted ILM Peeling
Sponsored by
Federal University of São Paulo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Macular Holes focused on measuring macular holes

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

> Stage 3 and 4 macular holes with visual acuity between 20/30 and 20/800 according to the ETDRS chart.

Exclusion Criteria:

  • Macular holes secondary to ocular trauma, myopia or retinal detachment
  • Any previous treatment for the macular hole
  • Evidence on examination of any diabetic retinopathy
  • History or presence of wet or dry age macular degeneration (AMD)
  • Presence of epiretinal membrane or prior uveitis
  • Any ocular surgery within 3 months before baseline
  • Intra or periocular infection

Sites / Locations

  • Dept. of OphthalmologyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Group A: Conventional ILM peeling

GroupB: Inverted ILM Peeling

Arm Description

peeling with complete removal of the internal limiting membrane (ILM)

the inverted ILM peeling technique, in which the ILM is left in the edge of the macular hole and the free area is inverted over the macular hole before fluid-air exchange

Outcomes

Primary Outcome Measures

Rate of Anatomic closure
Rate of anatomic macular hole closure in the OCT at month 6

Secondary Outcome Measures

BCVA mean
mean best corrected visual acuity (BCVA) at month 6
BCVA change
change in the BCVA at month 6
Integrity Membrane measured in microns (μm) by OCT
In the month 6, the area of discontinuity of the perifoveal external limiting membrane and ellipsoid zone in the OCT images will be measured in microns (μm) and correlated between groups

Full Information

First Posted
March 21, 2019
Last Updated
March 22, 2019
Sponsor
Federal University of São Paulo
search

1. Study Identification

Unique Protocol Identification Number
NCT03888625
Brief Title
Compare the Healing Process of Idiopathic Macular Hole With Different Surgical Techniques
Official Title
Randomized Clinical Trials to Compare the Healing Process of Idiopathic Macular Hole With Different Surgical Techniques
Study Type
Interventional

2. Study Status

Record Verification Date
March 2019
Overall Recruitment Status
Unknown status
Study Start Date
June 15, 2018 (Actual)
Primary Completion Date
June 15, 2020 (Anticipated)
Study Completion Date
June 30, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federal University of São Paulo

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To compare anatomic and functional results, and to evaluate postoperatively the healing process in 2 different techniques for the closure of the macular holes (MH)
Detailed Description
Patients with macular holes classified in stages 3 and 4 will be randomized into 2 groups. . In Group A, patients will undergo peeling with complete removal of the internal limiting membrane (ILM) and in the group B, the inverted ILM peeling technique will be performed. The 20% sulfur hexafluoride (SF6) gas will be used as a tamponade agent in all surgeries, and patients will be instructed to avoid the prone position for 5 days. OCT images will be performed in the first 5 postoperative days and months 1, 3 and 6. The primary outcome is anatomic closure of the MH closure in the month 6. The second outcomes are: mean best corrected visual acuity (BCVA) at month 6, mean change in the BCVA at month 6; integrity of the perifoveal external limiting membrane and ellipsoid zone on Optical Coherence Tomography (OCT); MH closure rate over time in days; functional improvement of microperimetry Statistical analysis will be performed with Student t-test and the p-value of ≤ 0.05 is considered significant.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Macular Holes
Keywords
macular holes

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
In Group A, patients will undergo peeling with complete removal of the internal limiting membrane (ILM) and in the group B, the inverted ILM peeling technique will be performed.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Group A: Conventional ILM peeling
Arm Type
Active Comparator
Arm Description
peeling with complete removal of the internal limiting membrane (ILM)
Arm Title
GroupB: Inverted ILM Peeling
Arm Type
Active Comparator
Arm Description
the inverted ILM peeling technique, in which the ILM is left in the edge of the macular hole and the free area is inverted over the macular hole before fluid-air exchange
Intervention Type
Procedure
Intervention Name(s)
Conventional ILM Peeling
Intervention Description
peeling with complete removal of the internal limiting membrane (ILM)
Intervention Type
Procedure
Intervention Name(s)
Inverted ILM Peeling
Intervention Description
the inverted ILM peeling technique - the technique of Inverted flap described by Michalewska, in which the ILM is left in the edge of the macular hole and the free area is inverted over the macular hole before fluid-air exchange
Primary Outcome Measure Information:
Title
Rate of Anatomic closure
Description
Rate of anatomic macular hole closure in the OCT at month 6
Time Frame
Month 6 post operative
Secondary Outcome Measure Information:
Title
BCVA mean
Description
mean best corrected visual acuity (BCVA) at month 6
Time Frame
Month 6 post operative
Title
BCVA change
Description
change in the BCVA at month 6
Time Frame
Screening and Month 6 post operative
Title
Integrity Membrane measured in microns (μm) by OCT
Description
In the month 6, the area of discontinuity of the perifoveal external limiting membrane and ellipsoid zone in the OCT images will be measured in microns (μm) and correlated between groups
Time Frame
Month 6 post operative

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: > Stage 3 and 4 macular holes with visual acuity between 20/30 and 20/800 according to the ETDRS chart. Exclusion Criteria: Macular holes secondary to ocular trauma, myopia or retinal detachment Any previous treatment for the macular hole Evidence on examination of any diabetic retinopathy History or presence of wet or dry age macular degeneration (AMD) Presence of epiretinal membrane or prior uveitis Any ocular surgery within 3 months before baseline Intra or periocular infection
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mauricio Maia, MD, PhD
Phone
+55-18-991137727
Email
maiamauricio@terra.com.br
First Name & Middle Initial & Last Name or Official Title & Degree
Luci p Silva, PhD, MBA
Phone
11971571967
Email
luci.pesquisa@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mauricio Maia, MD, PhD
Organizational Affiliation
Federal University of São Paulo
Official's Role
Study Director
Facility Information:
Facility Name
Dept. of Ophthalmology
City
São Paulo
ZIP/Postal Code
04023-062
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mauricio Maia, MD, PhD
Phone
1155764848
Ext
2265
Email
maiamauricio@terra.com.br
First Name & Middle Initial & Last Name & Degree
Luci p Silva, PhD, MBA
Phone
11971571967
Email
luci.pesquisa@gmail.com
First Name & Middle Initial & Last Name & Degree
Luiz Felipe A Lucatto, MD
First Name & Middle Initial & Last Name & Degree
Octaviano Magalhães Júnior, PhD, MD
First Name & Middle Initial & Last Name & Degree
Felipe Muralha, MD
First Name & Middle Initial & Last Name & Degree
Alex Grupenmacher, MD
First Name & Middle Initial & Last Name & Degree
Francisco Stefanini, MD
First Name & Middle Initial & Last Name & Degree
Muller G Urias, MD
First Name & Middle Initial & Last Name & Degree
Maia Mauricio, PhD, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Compare the Healing Process of Idiopathic Macular Hole With Different Surgical Techniques

We'll reach out to this number within 24 hrs